RPRX
Royalty Pharma plc · Healthcare
EVP, Research & Investments Marshall Urist sold $502K of Royalty Pharma plc
Sold$502,067
$55.18Price
9,098Shares
−50%Stake
What RPRX did after the filing
- The stock from Fri, Jun 26 open, $54.60
- +6.2%
- S&P 500, same days
- +6.0%
Measured over 30 trading days, to the Aug 10 close.
Traded Wed, Jun 24. Filed Thu, Jun 25, 5:13 PM ET, after the close. Returns use the Jun 26 open and the Aug 10 close. Not investment advice.